NFKB1 and hepatocellular carcinoma: Considering that NF-κB activation was responsible for the explosive expression of various inflammatory genes, and NF-κB inhibition suppressed ACSL1 expression in hepatocellular carcinoma cells [58], we checked whether NF-κB inhibition attenuated ACSL1 expression.